The molecular mechanism by which TRAF6 regulates the immune system

A single protein called TRAF6 acts as a master switch for the immune system, but its most critical functions do not work the way scientists long assumed. This matters because TRAF6 controls how the body responds to infections, inflammation, and even cancer. The researchers have discovered that the protein’s well-known enzymatic activity—its ability to tag other proteins with ubiquitin—is not needed for many of its essential roles. Instead, that activity actually *restricts* T cell activation, preventing the immune system from attacking the body’s own tissues. This overturns a decade of textbook understanding and opens a gap in knowledge about how immune signals are really transmitted. If this fundamental science succeeds, it could reveal new molecular levers for controlling immune responses. Understanding how TRAF6 restrains T cells might suggest ways to release those cells against tumours, improving cancer immunotherapy. Deciphering the newly discovered IL-1 signalling pathway—which activates the master kinase TAK1 without its usual partners—could lead to better treatments for inflammatory diseases. This is curiosity-driven research into the basic wiring of the immune system, but similar fundamental discoveries about immune checkpoints have already transformed cancer treatment.